Quarterly report [Sections 13 or 15(d)]

Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details)

v3.26.3
Divestitures - Key Components of Net (Loss) Income from Discontinued Operations (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cost of revenues:        
(Loss) income before income tax expense $ (1,593,877) $ 664,269 $ (313,375) $ 3,424,697
Income tax (benefit) expense from discontinued operations (20,197) 99,630 159,613 303,243
Net (loss) income from discontinued operations (1,573,680) 564,639 (472,988) 3,121,454
Corporate Clinics        
Cost of revenues:        
Income tax (benefit) expense from discontinued operations (20,197) 99,630 159,613 303,243
Net (loss) income from discontinued operations (1,573,680) 564,639 (472,988) 3,121,454
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Corporate Clinics        
Revenues:        
Total revenues 4,186,181 10,520,596 21,132,289 44,068,960
Cost of revenues:        
Total cost of revenues 2,770 4,181 13,857 15,906
Selling and marketing expenses 302,682 1,012,959 2,043,881 4,731,358
Depreciation and amortization 134 16,310 9,581 59,815
General and administrative expenses 3,348,346 7,942,168 16,045,972 32,070,385
Total selling, general and administrative expenses 3,651,162 8,971,437 18,099,434 36,861,558
Net loss on disposition or impairment from discontinued operations 2,084,596 860,598 3,278,826 3,746,449
(Loss) income from discontinued operations (1,552,347) 684,380 (259,828) 3,445,047
Other expense, net 41,530 20,111 53,547 20,350
(Loss) income before income tax expense $ (1,593,877) $ 664,269 $ (313,375) $ 3,424,697